EUSA Pharma wins FDA approval for trial of siltuximab to treat ARDS

EUSA Pharma will proceed with the placebo-controlled clinical trial to evaluate the safety and efficacy of siltuximab to treat Covid-19 associated ARDS. Credit: James Heilman, MD.